25) , 26) , 27) Evidence for NOAC use in the treatment of VTE shows a clear trend for replacing VKA use. 28) , 29) , 30) , 31) Physician awareness on the efficacy and safety of NOACs is important to initiate NOAC prescription; however, the clinical availability of NOACs in real clinical practice is affected out-of-pocket patient cost.
← all excerpts
Epidemiology of Venous Thromboembolism and Treatment Pattern of Oral Anticoagulation in Korea, 2009-2016: a Nationwide Study Based on the National Health Insurance Service Database.
1
—
—